Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman et al. · American Heart Journal · 2010 · 482 citations

Medicine, Cardiology, Pharmacology +14

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Koichiro Ogata, Jeanne Mendell‐Harary, Masaya Tachibana et al. · The Journal of Clinical Pharmacology · 2010 · 448 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles

Taketoshi Furugohri, K. Isobe, Yuko Honda et al. · Journal of Thrombosis and Haemostasis · 2008 · 300 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents

Toshio Fukuda, Yuko Honda, Chikako Kamisato et al. · Thrombosis and Haemostasis · 2011 · 133 citations

Medicine, Hematology, Pharmacology +17

Safety and efficacy of edoxaban in patients undergoing hip fracture surgery

Takeshi Fuji, Satoru Fujita, Yohko Kawai et al. · Thrombosis Research · 2014 · 102 citations · Full text

Pharmacy, Orthopaedic Surgery, Pharmacotherapy +17